AnalystsJamie ClarkJamie Clark's Stock Forecasts
AnalystsJamie Clark
Sectors:
Analyst Ranking
Bottom 50%
#2617 out of 5213 analysts
Average Return
+1.59%
Win Rate
57%4 out of 7
Risk vs Reward
Poor
Good
Jamie Clark's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Charles River Laboratories International IncCRL | +23.54% | $136.73 | $168.91 | 2025-05-23 - 2026-03-11 | Strong Buy |
Quest Diagnostics IncDGX | +19.41% | $167.96 | $200.56 | 2025-04-02 - 2026-03-11 | Strong Buy |
Charles River Laboratories International IncCRL | +15.35% | $193.14 | $163.50 | 2024-10-14 - 2025-03-03 | Strong Sell |
Labcorp Holdings IncLH | +14.41% | $236.37 | $270.42 | 2025-04-02 - 2026-03-11 | Strong Buy |
Jamie Clark Analyst Color
Get additional color on Jamie Clark's coverage of popular stocks
Jamie Clark's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
West Pharmaceutical Services IncWST | 1 | Strong Buy | $311.00 | +30.54% | Initiates Coverage On | 6 months ago |
Medpace Holdings IncMEDP | 1 | Hold | $474.00 | -0.78% | Downgrades | 6 months ago |
Icon PLCICLR | 1 | Strong Buy | $236.00 | +123.95% | Upgrades | 6 months ago |
Charles River Laboratories International IncCRL | 3 | Strong Buy | $182.00 | +7.75% | Upgrades | 10 months ago |
Labcorp Holdings IncLH | 1 | Strong Buy | $276.00 | +2.06% | Initiates Coverage On | a year ago |
Quest Diagnostics IncDGX | 1 | Strong Buy | $195.00 | -2.77% | Initiates Coverage On | a year ago |
Iqvia Holdings IncIQV | 1 | Strong Buy | $276.00 | N/A | Initiates Coverage On | a year ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.